Bharat Immunologicals (India) Buy or Sell Recommendation

Macroaxis provides Bharat Immunologicals Biologicals Corp Ltd buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Bharat Immunologicals positions. The advice algorithm takes into account all of Bharat Immunologicals Biologicals Corp Ltd available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Bharat Immunologicals buy-and-hold prospective. Check also Bharat Immunologicals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Investment Horizon


Risk Tolerance

Execute Advice
Bharat Immunologicals Biologicals Corp Ltd -- India Stock  

INR 22.45  0.05  0.22%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Bharat Immunologicals Biologicals Corp Ltd is 'Strong Hold'.
For the selected time horizon Bharat Immunologicals Biologicals Corp Ltd has a risk adjusted performance of 0.0217, jensen alpha of (0.33), total risk alpha of (1.12), sortino ratio of (0.003674) and treynor ratio of 0.0327
Macroaxis buy, hold, or sell recommendation module can be used to complement current analysts and expert consensus on Bharat Immunologicals. Our buy, hold, or sell suggestion engine makes use of analyzes the corporation potential to grow using all fundamental data market data available at the time. To make sure Bharat Immunologicals is not overpriced, please confirm all Bharat Immunologicals fundamentals including its Gross Profit, Debt to Equity and the relationship between Price to Book and Cash and Equivalents .

Returns Distribution Density

Mean Return0.13Value At Risk-2.5696
Potential Upside4.793Standard Deviation2.2776
 Return Density 

Bharat Immunologicals Greeks

Alpha over DOW
βBeta against DOW= 3.58 
Overall volatility
= 2.28 
 IrInformation ratio =(0.0031) 

Bharat Immunologicals Volatility Alert

Bharat Immunologicals Biologicals Corp Ltd has relatively low volatility with skewness of 0.8 and kurtosis of 0.99. However, we advise all investors to independently investigate Bharat Immunologicals Biologicals Corp Ltd to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.
 Better Than Average     
 Worse Than Average Compare Bharat Immunologicals to competition
FundamentalsBharat ImmunologicalsPeer Average
Return On Asset(1.69) % (15.64) %
Profit Margin(4.18) % (5.5) %
Operating Margin(5.13) % (10.91) %
Current Valuation862.5 M152.14 B
Shares Outstanding43.18 M1.43 B
Price to Earning(17.66) times40.69 times
Price to Book2.5 times14.44 times
Price to Sales0.66 times17.81 times
Revenue1.28 B9.85 B
Gross Profit119 M21.75 B
EBITDA(56.51 M)1.41 B
Net Income(53.46 M)517.71 M
Cash and Equivalents152.27 M3.89 B
Cash per Share3.55 times5.17 times
Total Debt177.56 M7.36 B
Debt to Equity0.5 times0.72 times
Current Ratio1.69 times3.3 times
Earnings Per Share(1.24) times2.3 times
Number of Employees510.67 K
Market Capitalization945.64 M29.78 B
Z Score3.0708.73
Strong Hold


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Currently Unavailable

Piotroski F Score

Currently Unavailable

Financial Leverage

Risk Adjusted Performance0.0217
Market Risk Adjusted Performance0.0427
Mean Deviation1.55
Semi Deviation1.78
Downside Deviation1.91
Coefficient Of Variation1794.72
Standard Deviation2.28
Information Ratio(0.003083)
Jensen Alpha(0.33)
Total Risk Alpha(1.12)
Sortino Ratio(0.003674)
Treynor Ratio0.0327
Maximum Drawdown7.36
Value At Risk(2.57)
Potential Upside4.79
Downside Variance3.65
Semi Variance3.18
Expected Short fall(1.83)